Patient demographics
| Characteristic | Overall | |
|---|---|---|
| n | % | |
| Number | 24 | |
| Age | ||
| Range | 35-70 | |
| Median | 60 | |
| Sex | ||
| Male | 17 | 71% |
| Female | 7 | 39% |
| Stage | ||
| II | 4 | 16.5% |
| III | 16 | 67% |
| IV | 4 | 16.5% |
| Karnofsky performance status | ||
| 90% | 7 | 29% |
| 100% | 16 | 67% |
| Unknown | 1 | 4% |
| Prior therapy | ||
| None | 17 | 71% |
| Temozolomide alone | 1 | 4.1% |
| Radiation alone | 2 | 8.3% |
| RSA ablation | 1 | 4.1% |
| Interferon | 1 | 4.1% |
| Temozolomide + | 1 | 4.1% |
| Radiation | ||
| Temozolomide + | 1 | 4.1% |
| Isolated limb infusion | ||